Esperion Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.

About ESPR

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.

CEO

Sheldon L. Koenig

CEOSheldon L. Koenig

Employees

304

Employees304

Headquarters

Ann Arbor, Michigan

HeadquartersAnn Arbor, Michigan

Founded

1998

Founded1998

Employees

304

Employees304

ESPR Key Statistics

Market cap

238.83M

Market cap238.83M

Price-Earnings ratio

-1.51

Price-Earnings ratio-1.51

Dividend yield

—

Dividend yield—

Average volume

4.88M

Average volume4.88M

High today

$1.28

High today$1.28

Low today

$1.13

Low today$1.13

Open price

$1.21

Open price$1.21

Volume

3.76M

Volume3.76M

52 Week high

$3.94

52 Week high$3.94

52 Week low

$0.6925

52 Week low$0.6925

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

25%

Sell

12.5%

People also own

Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.